Abstract

The Human Toxome Project is part of a long-term vision to modernize toxicity testing for the 21st century. In the initial phase of the project, a consortium of six academic, commercial, and government organizations has partnered to map pathways of toxicity, using endocrine disruption as a model hazard. Experimental data is generated at multiple sites, and analyzed using a range of computational tools. While effectively gathering, managing, and analyzing the data for high-content experiments is a challenge in its own right, doing so for a growing number of -omics technologies, with larger data sets, across multiple institutions complicates the process. Interestingly, one of the most difficult, ongoing challenges has been the computational collaboration between the geographically separate institutions. Existing solutions cannot handle the growing heterogeneous data, provide a computational environment for consistent analysis, accommodate different workflows, and adapt to the constantly evolving methods and goals of a research project. To meet the needs of the project, we have created and managed The Human Toxome Collaboratorium, a shared computational environment hosted on third-party cloud services. The Collaboratorium provides a familiar virtual desktop, with a mix of commercial, open-source, and custom-built applications. It shares some of the challenges of traditional information technology, but with unique and unexpected constraints that emerge from the cloud. Here we describe the problems we faced, the current architecture of the solution, an example of its use, the major lessons we learned, and the future potential of the concept. In particular, the Collaboratorium represents a novel distribution method that could increase the reproducibility and reusability of results from similar large, multi-omic studies.

Highlights

  • The Human Toxome Project is part of an ongoing effort to modernize toxicity testing with new technologies and a better understanding of toxicological mechanisms (National Research Council, 2007; Stephens et al, 2013)

  • In order to test the concept and develop the techniques (Perkel, 2012; Baker, 2013; Bouhifd et al, 2014), endocrine disruption in the human breast adenocarcinoma cell line MCF-7 (Soule et al, 1973) was chosen as a model system, and the experimental and computational work was spread across a consortium of six institutions that span the spectrum of academic, government, and commercial interests: Agilent Technologies, Brown University, Georgetown University, Johns Hopkins University (JHU) and its Center for Alternatives to Animal Testing (CAAT), the Hamner Institutes for Health Sciences, and the United States Environmental Protection Agency (EPA) (Hartung et al, 2012, 2013; Bouhifd et al, 2015)

  • We present our own solution, The Human Toxome Collaboratorium, a shared computational environment hosted on third-party cloud services

Read more

Summary

Introduction

The Human Toxome Project is part of an ongoing effort to modernize toxicity testing with new technologies and a better understanding of toxicological mechanisms (National Research Council, 2007; Stephens et al, 2013). We present our own solution, The Human Toxome Collaboratorium, a shared computational environment hosted on third-party cloud services.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.